Cargando…
Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104711/ https://www.ncbi.nlm.nih.gov/pubmed/32231330 http://dx.doi.org/10.1038/s41569-020-0369-9 |
| _version_ | 1783512290285322240 |
|---|---|
| author | Zheng, Ying-Ying Ma, Yi-Tong Zhang, Jin-Ying Xie, Xiang |
| author_facet | Zheng, Ying-Ying Ma, Yi-Tong Zhang, Jin-Ying Xie, Xiang |
| author_sort | Zheng, Ying-Ying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7104711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71047112020-03-31 Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ Zheng, Ying-Ying Ma, Yi-Tong Zhang, Jin-Ying Xie, Xiang Nat Rev Cardiol Correspondence Nature Publishing Group UK 2020-03-30 2020 /pmc/articles/PMC7104711/ /pubmed/32231330 http://dx.doi.org/10.1038/s41569-020-0369-9 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Zheng, Ying-Ying Ma, Yi-Tong Zhang, Jin-Ying Xie, Xiang Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title | Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title_full | Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title_fullStr | Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title_full_unstemmed | Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title_short | Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
| title_sort | reply to: ‘interaction between raas inhibitors and ace2 in the context of covid-19’ |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104711/ https://www.ncbi.nlm.nih.gov/pubmed/32231330 http://dx.doi.org/10.1038/s41569-020-0369-9 |
| work_keys_str_mv | AT zhengyingying replytointeractionbetweenraasinhibitorsandace2inthecontextofcovid19 AT mayitong replytointeractionbetweenraasinhibitorsandace2inthecontextofcovid19 AT zhangjinying replytointeractionbetweenraasinhibitorsandace2inthecontextofcovid19 AT xiexiang replytointeractionbetweenraasinhibitorsandace2inthecontextofcovid19 |